Earth Science Tech Inc Revenue Growth Rates (ETST), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Earth Science Tech Inc   (ETST)
 

ETST's Revenue Growth by Quarter and Year

Earth Science Tech Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ETST/growth
https://api.csimarket.com/api/v1/companies/ETST/fundamentals
https://api.csimarket.com/api/v1/companies/ETST/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ETST Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter March -
3rd Quarter December -
2nd Quarter September 7.30
1st Quarter June 9.03
FY 16.33

ETSTs Annual Revenue
Earth Science Tech Inc 's Revenue in the fiscal year 2026 $ 35.70 millions
Earth Science Tech Inc 's Revenue in the fiscal year 2025 $ 32.30 millions
Earth Science Tech Inc 's Revenue in the fiscal year 2024 $ 11.95 millions
Earth Science Tech Inc 's Revenue in the fiscal year 2023 $ 0.05 millions
Earth Science Tech Inc 's Revenue in the fiscal year 2022 $ 0.01 millions




ETST Revenue second quarter 2026 Y/Y Growth Comment
Earth Science Tech Inc reported decline in Revenue in the second quarter 2026 by -16.29% to $ 7.30 millions, from the same quarter in 2025.
The contraction in the second quarter 2026 Earth Science Tech Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 4386.41%.

Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 116 other companies have achieved higher Revenue growth. While Earth Science Tech Inc ' s Revenue fall of -16.29% ranks overall at the positon no. 1511 in the second quarter 2026.


ETST Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter March -
3rd Quarter December -
2nd Quarter September -16.29 %
1st Quarter June 11.62 %
FY   -

Financial Statements
Earth Science Tech Inc 's second quarter 2026 Revenue $ 7.30 millions ETST's Income Statement
Earth Science Tech Inc 's second quarter 2025 Revenue $ 8.72 millions Quarterly ETST's Income Statement


ETST Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter March -
3rd Quarter December -
2nd Quarter September -19.16 %
1st Quarter June -4.95 %
FY (Year on Year)   -


Back to ETST Growth rate Comparisons >> Back to ETST Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #117
Healthcare Sector #278
Overall #1511

Revenue Y/Y Growth Statistics
High Average Low
133208.25 % 4386.41 % -100 %
(Sep 30 2024)   (Mar 31 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #117
Healthcare Sector #278
Overall #1511
Revenue Y/Y Growth Statistics
High Average Low
133208.25 % 4386.41 % -100 %
(Sep 30 2024)   (Mar 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Earth Science Tech Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1716.19 % 70.63 % -100 %
(Mar 31 2023)  


ETST's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Earth Science Tech Inc disclosed fall in Revenue from the first quarter by -19.16% to $ 7.30 millions, from $ 9.03 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 156 other companies have achieved higher Revenue quarter on quarter growth. While Earth Science Tech Inc 's Revenue growth quarter on quarter, overall rank is 3224.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #449
Overall #3224
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #157
Healthcare Sector #449
Overall #3224
Revenue Q/Q Growth Statistics
High Average Low
1716.19 % 70.63 % -100 %
(Mar 31 2023)  


ETST's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Earth Science Tech Inc disclosed fall in Revenue from the first quarter by -19.16% to $ 7.30 millions, from $ 9.03 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Major Pharmaceutical Preparations's company achievement, Most analysts pointed out.

Within Major Pharmaceutical Preparations industry 156 other companies have achieved higher Revenue quarter on quarter growth. While Earth Science Tech Inc 's Revenue growth quarter on quarter, overall rank is 3224.


Earth Science Tech Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 34.65
Y / Y Revenue Growth (TTM) 6.15 %
Year on Year Revenue Growth Overall Ranking # 238
Seqeuential Revenue Change (TTM) 2.77 %
Seq. Revenue Growth (TTM) Overall Ranking # 2646


Cumulative Revenue growth Comment
Although Earth Science Tech Inc 's Annual Revenue growth year on year were below company's average 66.08% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.15% year on year, from 1.79% in Mar 31 2026.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1 to 238.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 59
Overall # 238

Revenue TTM Y/Y Growth Statistics
High Average Low
1105.75 %
 66.08 %
-89.98 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 379
S&P 500 # 2646
Cumulative Revenue growth Comment
Although Earth Science Tech Inc 's Annual Revenue growth year on year were below company's average 66.08% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.15% year on year, from 1.79% in Mar 31 2026.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1 to 238.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 131
Healthcare Sector # 59
Overall # 238

Revenue TTM Y/Y Growth Statistics
High Average Low
1105.75 %
66.08 %
-89.98 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 379
S&P 500 # 2646




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ETST's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Viatris Inc -0.28%$ -0.277 millions
Zoetis Inc -0.38%$ -0.375 millions
Pfizer Inc-0.43%$ -0.426 millions
Standard Biotools Inc -0.51%$ -0.508 millions
Lucid Diagnostics Inc -0.66%$ -0.661 millions
Globus Medical Inc -0.69%$ -0.693 millions
Conmed Corporation-0.70%$ -0.701 millions
Surgery Partners Inc -0.75%$ -0.755 millions
Myriad Genetics Inc -1.03%$ -1.025 millions
Lensar Inc -1.29%$ -1.292 millions
Fortrea Holdings Inc -1.40%$ -1.397 millions
Immunocore Holdings Plc-1.42%$ -1.419 millions
Pacira Biosciences inc -1.59%$ -1.595 millions
Organon and Co -1.75%$ -1.748 millions
Teva Pharmaceutical Industries Limited-1.90%$ -1.897 millions
Skinhealth Systems Inc -2.07%$ -2.071 millions
Charles River Laboratories International inc -2.20%$ -2.201 millions
Inogen Inc -2.40%$ -2.399 millions
Novavax inc -3.05%$ -3.048 millions
Seer Inc -3.14%$ -3.139 millions
Teladoc Health Inc -3.41%$ -3.406 millions
Cg Oncology Inc -3.72%$ -3.721 millions
Treace Medical Concepts Inc -3.91%$ -3.905 millions
Sarepta Therapeutics Inc -4.51%$ -4.509 millions
Pacific Health Care Organization Inc-4.69%$ -4.689 millions
Tela Bio Inc -5.06%$ -5.058 millions
Perrigo Company Plc-5.22%$ -5.225 millions
Heron Therapeutics Inc -5.49%$ -5.493 millions
Sutro Biopharma Inc -6.14%$ -6.138 millions
Zai Lab Limited-6.79%$ -6.794 millions


About Earth Science Tech Inc Revenue Growth Rates (ETST), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Earth Science Tech Inc (CIK 1538495).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-050720
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Earth Science Tech Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.